Cargando…

A Neonate with a Diagnosis of Pontocerebellar Hypoplasia Type 6 Treated with Biotin and Developed Biotin Interference with Laboratory Thyroid Function Tests

Patient: Male, 2-year-old Final Diagnosis: Pontocerebellar hypoplasia type 6 Symptoms: Feeding problems • lactic acidosis Medication: — Clinical Procedure: — Specialty: Endocrinology and Metabolic OBJECTIVE: Unusual clinical course BACKGROUND: The interference of biotin administration with thyroid f...

Descripción completa

Detalles Bibliográficos
Autores principales: Nagafuji, Motomichi, Hitaka, Daisuke, Iwabuchi, Atsushi, Miyazono, Yayoi, Takada, Hidetoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8711254/
https://www.ncbi.nlm.nih.gov/pubmed/34930889
http://dx.doi.org/10.12659/AJCR.934417
_version_ 1784623332942938112
author Nagafuji, Motomichi
Hitaka, Daisuke
Iwabuchi, Atsushi
Miyazono, Yayoi
Takada, Hidetoshi
author_facet Nagafuji, Motomichi
Hitaka, Daisuke
Iwabuchi, Atsushi
Miyazono, Yayoi
Takada, Hidetoshi
author_sort Nagafuji, Motomichi
collection PubMed
description Patient: Male, 2-year-old Final Diagnosis: Pontocerebellar hypoplasia type 6 Symptoms: Feeding problems • lactic acidosis Medication: — Clinical Procedure: — Specialty: Endocrinology and Metabolic OBJECTIVE: Unusual clinical course BACKGROUND: The interference of biotin administration with thyroid function tests has been reported; however, it remains unclear in clinical practice. In this report, we present the case of a neonate with a diagnosis of pontocerebellar hypoplasia type 6 (PCH6) treated with biotin who developed biotin interference with laboratory thyroid function tests. CASE REPORT: A 1-day-old male infant with hypothermia, tachypnea, and lactic acidosis had a suspected diagnosis of mitochondrial disease. Biotin and several vitamins were administered to improve his condition. On day 14, his laboratory tests revealed a free triiodothyronine level of 4.7 pg/mL, free thyroxine level of 3.7 ng/dL, thyroid-stimulating hormone level of 0.07 μIU/mL, and thyroid-stimulating hormone receptor antibody (TRAb) level of 37.6 IU/L, suggesting Graves’ disease. No goiter or tachycardia developed. The maternal thyroid function was not measured during pregnancy, while the maternal TRAb was negative on the same day. After methimazole administration, the patient’s thyroid function normalized, and methimazole was therefore discontinued. All thyroid function tests were conducted using immunoassay methods with avidin and biotin. Later, reduced oxygen consumption under aerobic conditions in skin fibroblasts and compound heterozygous variants of the mitochondrial arginine tRNA synthetase gene were identified, and the patient was diagnosed with PCH6. CONCLUSIONS: In this case, the clinical symptoms and physical findings were incompatible with the thyroid function. These laboratory findings could have mimicked Graves’ disease due to the biotin interference with immunoassays. Therefore, caution is required when evaluating similar cases.
format Online
Article
Text
id pubmed-8711254
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher International Scientific Literature, Inc.
record_format MEDLINE/PubMed
spelling pubmed-87112542022-01-13 A Neonate with a Diagnosis of Pontocerebellar Hypoplasia Type 6 Treated with Biotin and Developed Biotin Interference with Laboratory Thyroid Function Tests Nagafuji, Motomichi Hitaka, Daisuke Iwabuchi, Atsushi Miyazono, Yayoi Takada, Hidetoshi Am J Case Rep Articles Patient: Male, 2-year-old Final Diagnosis: Pontocerebellar hypoplasia type 6 Symptoms: Feeding problems • lactic acidosis Medication: — Clinical Procedure: — Specialty: Endocrinology and Metabolic OBJECTIVE: Unusual clinical course BACKGROUND: The interference of biotin administration with thyroid function tests has been reported; however, it remains unclear in clinical practice. In this report, we present the case of a neonate with a diagnosis of pontocerebellar hypoplasia type 6 (PCH6) treated with biotin who developed biotin interference with laboratory thyroid function tests. CASE REPORT: A 1-day-old male infant with hypothermia, tachypnea, and lactic acidosis had a suspected diagnosis of mitochondrial disease. Biotin and several vitamins were administered to improve his condition. On day 14, his laboratory tests revealed a free triiodothyronine level of 4.7 pg/mL, free thyroxine level of 3.7 ng/dL, thyroid-stimulating hormone level of 0.07 μIU/mL, and thyroid-stimulating hormone receptor antibody (TRAb) level of 37.6 IU/L, suggesting Graves’ disease. No goiter or tachycardia developed. The maternal thyroid function was not measured during pregnancy, while the maternal TRAb was negative on the same day. After methimazole administration, the patient’s thyroid function normalized, and methimazole was therefore discontinued. All thyroid function tests were conducted using immunoassay methods with avidin and biotin. Later, reduced oxygen consumption under aerobic conditions in skin fibroblasts and compound heterozygous variants of the mitochondrial arginine tRNA synthetase gene were identified, and the patient was diagnosed with PCH6. CONCLUSIONS: In this case, the clinical symptoms and physical findings were incompatible with the thyroid function. These laboratory findings could have mimicked Graves’ disease due to the biotin interference with immunoassays. Therefore, caution is required when evaluating similar cases. International Scientific Literature, Inc. 2021-12-21 /pmc/articles/PMC8711254/ /pubmed/34930889 http://dx.doi.org/10.12659/AJCR.934417 Text en © Am J Case Rep, 2021 https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) )
spellingShingle Articles
Nagafuji, Motomichi
Hitaka, Daisuke
Iwabuchi, Atsushi
Miyazono, Yayoi
Takada, Hidetoshi
A Neonate with a Diagnosis of Pontocerebellar Hypoplasia Type 6 Treated with Biotin and Developed Biotin Interference with Laboratory Thyroid Function Tests
title A Neonate with a Diagnosis of Pontocerebellar Hypoplasia Type 6 Treated with Biotin and Developed Biotin Interference with Laboratory Thyroid Function Tests
title_full A Neonate with a Diagnosis of Pontocerebellar Hypoplasia Type 6 Treated with Biotin and Developed Biotin Interference with Laboratory Thyroid Function Tests
title_fullStr A Neonate with a Diagnosis of Pontocerebellar Hypoplasia Type 6 Treated with Biotin and Developed Biotin Interference with Laboratory Thyroid Function Tests
title_full_unstemmed A Neonate with a Diagnosis of Pontocerebellar Hypoplasia Type 6 Treated with Biotin and Developed Biotin Interference with Laboratory Thyroid Function Tests
title_short A Neonate with a Diagnosis of Pontocerebellar Hypoplasia Type 6 Treated with Biotin and Developed Biotin Interference with Laboratory Thyroid Function Tests
title_sort neonate with a diagnosis of pontocerebellar hypoplasia type 6 treated with biotin and developed biotin interference with laboratory thyroid function tests
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8711254/
https://www.ncbi.nlm.nih.gov/pubmed/34930889
http://dx.doi.org/10.12659/AJCR.934417
work_keys_str_mv AT nagafujimotomichi aneonatewithadiagnosisofpontocerebellarhypoplasiatype6treatedwithbiotinanddevelopedbiotininterferencewithlaboratorythyroidfunctiontests
AT hitakadaisuke aneonatewithadiagnosisofpontocerebellarhypoplasiatype6treatedwithbiotinanddevelopedbiotininterferencewithlaboratorythyroidfunctiontests
AT iwabuchiatsushi aneonatewithadiagnosisofpontocerebellarhypoplasiatype6treatedwithbiotinanddevelopedbiotininterferencewithlaboratorythyroidfunctiontests
AT miyazonoyayoi aneonatewithadiagnosisofpontocerebellarhypoplasiatype6treatedwithbiotinanddevelopedbiotininterferencewithlaboratorythyroidfunctiontests
AT takadahidetoshi aneonatewithadiagnosisofpontocerebellarhypoplasiatype6treatedwithbiotinanddevelopedbiotininterferencewithlaboratorythyroidfunctiontests
AT nagafujimotomichi neonatewithadiagnosisofpontocerebellarhypoplasiatype6treatedwithbiotinanddevelopedbiotininterferencewithlaboratorythyroidfunctiontests
AT hitakadaisuke neonatewithadiagnosisofpontocerebellarhypoplasiatype6treatedwithbiotinanddevelopedbiotininterferencewithlaboratorythyroidfunctiontests
AT iwabuchiatsushi neonatewithadiagnosisofpontocerebellarhypoplasiatype6treatedwithbiotinanddevelopedbiotininterferencewithlaboratorythyroidfunctiontests
AT miyazonoyayoi neonatewithadiagnosisofpontocerebellarhypoplasiatype6treatedwithbiotinanddevelopedbiotininterferencewithlaboratorythyroidfunctiontests
AT takadahidetoshi neonatewithadiagnosisofpontocerebellarhypoplasiatype6treatedwithbiotinanddevelopedbiotininterferencewithlaboratorythyroidfunctiontests